Publications by authors named "M Tena-Sempere"

Objective: AMP-activated protein kinase (AMPK) is a heterotrimer complex consisting of a catalytic α subunit (α1, α2) with a serine/threonine kinase domain, and two regulatory subunits, β (β1, β2) and γ (γ1, γ2, γ3), encoded by different genes. In the hypothalamus, AMPK plays a crucial role in regulating energy balance, including feeding, energy expenditure, peripheral glucose and lipid metabolism. However, most research on hypothalamic AMPK has concentrated on the catalytic subunits AMPKα1 and AMPKα2, with little focus on the regulatory subunits.

View Article and Find Full Text PDF

Female reproduction is highly sensitive to body energy stores; persistent energy deficit, as seen in anorexia or strenuous exercise, is known to suppress ovulation via ill-defined mechanisms. We report herein that hypothalamic SIRT1, a key component of the epigenetic machinery that links nutritional status and puberty onset via modulation of Kiss1, plays a critical role in the control of the preovulatory surge of gonadotropins, i.e.

View Article and Find Full Text PDF

Despite the diverse nature of obesity, there is compelling genetic, clinical, and experimental evidence that endorses the important contribution of brain circuits to this condition. The hypothalamus contains major regulatory circuits for bodyweight homoeostasis, the deregulation of which can lead to obesity. Although functional perturbation of hypothalamic pathways could lie at the basis of common forms of obesity, the term hypothalamic obesity has been created to define those rare forms of severe obesity where a clear hypothalamic substrate can be identified, either of genetic or acquired origin.

View Article and Find Full Text PDF
Article Synopsis
  • Polycystic ovary syndrome (PCOS) is a complex condition characterized by irregular ovulation, high levels of androgens, and the presence of polycystic ovaries, often leading to metabolic issues like obesity and insulin resistance.
  • Current treatments mainly address symptoms but are often ineffective for the underlying metabolic and reproductive problems.
  • Research shows that a GLP1-based treatment, specifically GLP1/Estrogen (GLP1/E), is more effective in managing PCOS-related metabolic complications and improving ovulation than other multi-agonists and metformin, suggesting a more personalized approach to treatment.
View Article and Find Full Text PDF